Form 4: Cardinal Health CEO Weitzman's PSU Grant

Deborah Weitzman, CEO of Cardinal Health's PSS Segment, reported the acquisition of 39,100 performance share units set to settle in August 2025.

Summary

• Deborah Weitzman, CEO of the PSS Segment at Cardinal Health Inc. (CAH), reported the acquisition of 39,100 common shares.
• These shares are performance share units (PSUs) acquired at a price of $0.
• The PSUs are scheduled to settle on August 15, 2025.
• Following this transaction, Weitzman beneficially owns 88,229 common shares directly.
• The filing also includes a Limited Power of Attorney, dated April 15, 2025, authorizing specific individuals to handle Weitzman's SEC reporting obligations.

Sentiment

Score: 7

Explanation: The filing reports a routine executive compensation event involving the grant of performance share units, which aligns executive incentives with company performance. This is generally viewed positively as it ties management's financial interests to shareholder value, without indicating any immediate negative operational or financial issues.

Positives

• Acquisition of 39,100 performance share units by a key executive indicates alignment of management incentives with shareholder interests.
• The grant of performance share units at a $0 price suggests these are part of an executive compensation package, often tied to future company performance.

Risks

• The Power of Attorney explicitly states that neither the Company nor any attorney-in-fact assumes liability for the undersigned's responsibility to comply with Exchange Act or Securities Act requirements, any failure to comply, or any obligation for profit disgorgement under Section 16(b) of the Exchange Act.
• The Power of Attorney does not relieve the undersigned from responsibility for compliance with obligations under the Exchange Act or Securities Act, including reporting requirements under Section 16.

Future Outlook

The filing indicates that 39,100 performance share units granted to Deborah Weitzman are set to settle on August 15, 2025, aligning executive incentives with future company performance.

Management Comments

• The undersigned hereby makes, constitutes, and appoints each of Jessica L. Mayer, James E. Barnett, Laura C. Dhaliwal, Amanda Pashi, Julie Gilbert, and any duly appointed Corporate Secretary of Cardinal Health, Inc. (the Company), with full power of substitution and re-substitution, acting individually, as the undersigneds true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place, and stead of the undersigned to... (various duties related to SEC reporting).

Industry Context

This Form 4 filing reflects a routine executive compensation event within the healthcare distribution industry, where performance-based equity grants are a standard practice to incentivize leadership and align their interests with long-term shareholder value.

Comparison to Industry Standards

• The grant of performance share units (PSUs) at a $0 price is a common form of executive compensation in large publicly traded companies across various sectors, including healthcare distribution.
• Companies like McKesson Corporation (MCK) and AmerisourceBergen Corporation (ABC), direct competitors of Cardinal Health, also frequently utilize similar equity-based compensation structures for their senior executives to tie pay to performance.
• The specific number of units granted (39,100) would typically be benchmarked against peer companies' executive compensation packages, considering the executive's role and the company's size and performance targets.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of performance share units aligns the interests of a key executive (CEO, PSS Segment) with shareholders, as the value of these units is tied to the company's future performance.
• Management: The filing details a component of executive compensation, providing a long-term incentive for the CEO of the PSS Segment.

Next Steps

• The 39,100 performance share units are scheduled to settle on August 15, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the grant of performance share units to a key executive. While it aligns management incentives with shareholder interests, it does not present new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment stance. It is a standard disclosure for insider holdings.

Keywords

Cardinal Health, CAH, Deborah Weitzman, Form 4, SEC filing, Performance Share Units, Executive Compensation, Insider Trading, Stock Grant, Healthcare Distribution